Cargando…
Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
Purpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but we...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504228/ https://www.ncbi.nlm.nih.gov/pubmed/34632866 http://dx.doi.org/10.1177/15330338211039135 |
_version_ | 1784581288711159808 |
---|---|
author | Biswas, Sharmi Kapitanova, Irina Divekar, Sabrina Grimm, Jimm Butterwick, Ian J. Garren, Daniel Kleinberg, Lawrence R. Redmond, Kristin J. Lacroix, Michel Mahadevan, Anand Forster, Kenneth M. |
author_facet | Biswas, Sharmi Kapitanova, Irina Divekar, Sabrina Grimm, Jimm Butterwick, Ian J. Garren, Daniel Kleinberg, Lawrence R. Redmond, Kristin J. Lacroix, Michel Mahadevan, Anand Forster, Kenneth M. |
author_sort | Biswas, Sharmi |
collection | PubMed |
description | Purpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but were not given simultaneously. This study evaluates the targeting accuracy of simultaneous radiation therapy while TTFields arrays are in place and powered on, ensuring that radiation does not interfere with TTFields and TTFields does not interfere with radiation. This is one of several options to enable TTFields to begin several weeks sooner, and opens potential for synergistic effects of combined therapy. Methods: TTFields arrays were attached to a warm saline water bath and salt was added until the TTFields generator reached the maximal 2000 mA peak-to-peak current. A ball cube phantom containing 2 orthogonal films surrounded by fiducials was placed in the water phantom, CT scanned, and a radiation treatment plan with 58 isocentric beams was created using a 3 cm circular collimator. Fiducial tracking was used to deliver radiation, the films were scanned, and end-to-end targeting error was measured with vendor-supplied software. In addition, radiation effects on electric fields generated by the TTFields system were assessed by examining logfiles generated from the field generator. Results: With TTFields arrays in place and powered on, the robotic radiosurgery system achieved a final targeting result of 0.47 mm, which was well within the submillimeter specification. No discernible effects on TTFields current output beyond 0.3% were observed in the logfiles when the radiation beam pulsed on and off. Conclusion: A robotic radiosurgery system was used to verify that radiation targeting was not adversely affected when the TTFields arrays were in place and the TTFields delivery device was powered on. In addition, this study verified that radiation delivered simultaneously with TTFields did not interfere with the generation of the electric fields. |
format | Online Article Text |
id | pubmed-8504228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-85042282021-10-12 Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy Biswas, Sharmi Kapitanova, Irina Divekar, Sabrina Grimm, Jimm Butterwick, Ian J. Garren, Daniel Kleinberg, Lawrence R. Redmond, Kristin J. Lacroix, Michel Mahadevan, Anand Forster, Kenneth M. Technol Cancer Res Treat Original Article Purpose: Tumor treating fields (TTFields) is a novel antimitotic treatment that was first proven effective for glioblastoma multiforme, now with trials for several extracranial indications underway. Several studies focused on concurrent TTFields therapy with radiation in the same time period, but were not given simultaneously. This study evaluates the targeting accuracy of simultaneous radiation therapy while TTFields arrays are in place and powered on, ensuring that radiation does not interfere with TTFields and TTFields does not interfere with radiation. This is one of several options to enable TTFields to begin several weeks sooner, and opens potential for synergistic effects of combined therapy. Methods: TTFields arrays were attached to a warm saline water bath and salt was added until the TTFields generator reached the maximal 2000 mA peak-to-peak current. A ball cube phantom containing 2 orthogonal films surrounded by fiducials was placed in the water phantom, CT scanned, and a radiation treatment plan with 58 isocentric beams was created using a 3 cm circular collimator. Fiducial tracking was used to deliver radiation, the films were scanned, and end-to-end targeting error was measured with vendor-supplied software. In addition, radiation effects on electric fields generated by the TTFields system were assessed by examining logfiles generated from the field generator. Results: With TTFields arrays in place and powered on, the robotic radiosurgery system achieved a final targeting result of 0.47 mm, which was well within the submillimeter specification. No discernible effects on TTFields current output beyond 0.3% were observed in the logfiles when the radiation beam pulsed on and off. Conclusion: A robotic radiosurgery system was used to verify that radiation targeting was not adversely affected when the TTFields arrays were in place and the TTFields delivery device was powered on. In addition, this study verified that radiation delivered simultaneously with TTFields did not interfere with the generation of the electric fields. SAGE Publications 2021-10-09 /pmc/articles/PMC8504228/ /pubmed/34632866 http://dx.doi.org/10.1177/15330338211039135 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Biswas, Sharmi Kapitanova, Irina Divekar, Sabrina Grimm, Jimm Butterwick, Ian J. Garren, Daniel Kleinberg, Lawrence R. Redmond, Kristin J. Lacroix, Michel Mahadevan, Anand Forster, Kenneth M. Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title | Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_full | Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_fullStr | Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_full_unstemmed | Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_short | Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy |
title_sort | targeting accuracy considerations for simultaneous tumor treating fields antimitotic therapy during robotic hypofractionated radiation therapy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504228/ https://www.ncbi.nlm.nih.gov/pubmed/34632866 http://dx.doi.org/10.1177/15330338211039135 |
work_keys_str_mv | AT biswassharmi targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT kapitanovairina targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT divekarsabrina targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT grimmjimm targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT butterwickianj targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT garrendaniel targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT kleinberglawrencer targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT redmondkristinj targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT lacroixmichel targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT mahadevananand targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy AT forsterkennethm targetingaccuracyconsiderationsforsimultaneoustumortreatingfieldsantimitotictherapyduringrobotichypofractionatedradiationtherapy |